Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers' Target?

By Yahoo! Finance | Sep 21, 2024 at 10:39 AM EST

In a recent article, Viking Therapeutics, Inc. (NASDAQ:VKTX) is analyzed against other worst booming stocks to buy according to short sellers. Despite being on the list, VKTX shows growth potential with an investigational obesity drug and strong financials.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.